Floating tablets for controlled release of ofloxacin via compression coating of hydroxypropyl cellulose combined with effervescent agent

International Journal of Pharmaceutics

Volumn 489, Issue 1-2, 2015, Pages 210-217

  Qi, Xiaole ^a   Chen, Haiyan ^a   Rui, Yao ^a   Yang, Fengjiao ^a   Ma, Ning ^a   Wu, Zhenghong ^a,b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Yangtze River Pharmaceutical Group   (China)

Author keywords

Compression coating; Floating tablets; Hydroxypropyl cellulose; Ofloxacin; Sodium alginate; Zero release

Indexed keywords

ALGINIC ACID; BICARBONATE; HYDROXYPROPYLCELLULOSE; MAGNESIUM STEARATE; OFLOXACIN; PEPSIN A; ANTIINFECTIVE AGENT; CELLULOSE; DELAYED RELEASE FORMULATION; GLUCURONIC ACID; HEXURONIC ACID; TABLET;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; DRUG BIOAVAILABILITY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG SOLUBILITY; GASTROINTESTINAL TRACT; NEW ZEALAND RABBIT; PRIORITY JOURNAL; SIMULATION; STOMACH JUICE; TABLET COMPRESSION; VISCOSITY; ANALOGS AND DERIVATIVES; ANIMAL; BIOAVAILABILITY; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG FORMULATION; DRUG RELEASE; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; RABBIT; TABLET;

ADMINISTRATION, ORAL; ALGINATES; ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL AVAILABILITY; CELLULOSE; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG LIBERATION; GASTRIC JUICE; GLUCURONIC ACID; HEXURONIC ACIDS; OFLOXACIN; RABBITS; SODIUM BICARBONATE; TABLETS;

EID: 84929150009     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.05.007     Document Type: Article

References (32)

1. S. Acharya, S. Patra, and N.R. Pani Optimization of HPMC and carbopol concentrations in non-effervescent floating tablet through factorial design Carbohydr. Polym. 102 2014 360 368
2. P.L. Bardonnet, V. Faivre, W.J. Pugh, J.C. Piffaretti, and F. Falson Gastroretentive dosage forms: overview and special case of Helicobacter pylori J. Controlled Release 111 2006 1 18
3. S. Baumgartner, J. Kristl, F. Vrečer, P. Vodopivec, and B. Zorko Optimisation of floating matrix tablets and evaluation of their gastric residence time Int. J. Pharm. 195 2000 125 135
4. M. Chavanpatil, P. Jain, S. Chaudhari, R. Shear, and P. Vavia Development of sustained release gastroretentive drug delivery system for ofloxacin: In vitro and in vivo evaluation Int. J. Pharm. 304 2005 178 184
5. M.D. Chavanpatil, P. Jain, S. Chaudhari, R. Shear, and P.R. Vavia Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin Int. J. Pharm. 316 2006 86 92
6. B.Y. Choi, H.J. Park, S.J. Hwang, and J.B. Park Preparation of alginate beads for floating drug delivery system: effects of CO2 gas-forming agents Int. J. Pharm. 239 2002 81 91
7. Y. Cui, Y. Zhang, and X. Tang In vitro and in vivo evaluation of ofloxacin sustained release pellets Int. J. Pharm. 360 2008 47 52
8. A.A. Deshpande, C.T. Rhodes, N.H. Shah, and A.W. Malick Controlled-release drug delivery systems for prolonged gastric residence: an overview Drug Dev. Ind. Pharm. 22 1996 531 539
9. M. Donbrow, and Y. Samuelov Zero order drug delivery from double-layered porous films: release rate profiles from ethyl cellulose, hydroxypropyl cellulose and polyethylene glycol mixtures J. Pharm. Pharm. 32 1980 463 470
10. P. Dorozyński, P. Kulinowski, A. Mendyk, and R. Jachowicz Gastroretentive drug delivery systems with l-dopa based on carrageenans and hydroxypropylmethylcellulose Int. J. Pharm. 404 2011 169 175
11. S.S. El Gamal, V.F. Naggar, and A.N. Allam Optimization of acyclovir oral tablets based on gastroretention technology: factorial design analysis and physicochemical characterization studies Drug Dev. Ind. Pharm. 37 2011 855 867
12. M.N. Gambhire, K.W. Ambade, S.D. Kurmi, V.J. Kadam, and K.R. Jadhav Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride AAPS PharmSciTech 8 2007 9
13. H.X. Guo, and Y.P. Shi A novel zein-based dry coating tablet design for zero-order release Int. J. Pharm. 370 2009 81 86
14. J. Hirtz The gastrointestinal absorption of drugs in man: a review of current concepts and methods of investigation Br. J. Clin. Pharm. 19 1985 77S 83S
15. L. Hu, L. Li, X. Yang, W. Liu, J. Yang, Y. Jia, C. Shang, and H. Xu Floating matrix dosage form for dextromethorphan hydrobromide based on gas forming technique: in vitro and in vivo evaluation in healthy volunteers Eur. J. Pharm. Sci. 42 2011 99 105
16. H. Huang, Z. Wu, X. Qi, H. Zhang, Q. Chen, J. Xing, H. Chen, and Y. Rui Compression-coated tablets of glipizide using hydroxypropylcellulose for zero-order release: in vitro and in vivo evaluation Int. J. Pharm. 446 2013 211 218
17. L. Kagan, and A. Hoffman Systems for region selective drug delivery in the gastrointestinal tract: biopharmaceutical considerations Expert Opin. Drug Delivery 5 2008 681 692
18. R.W. Korsmeyer, R. Gurny, E. Doelker, P. Buri, and N.A. Peppas Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air J. Pharm. Sci. 72 1983 1189 1191
19. J.-F. Marier, M.P. Ducharme, M. DiMarco, M. Di Spirito, G. Morelli, S.K. Tippabhotla, N. Badri, A. Rampal, and T. Monif Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediateand extended-release formulations in healthy subjects Clin. Ther. 28 2006 2070 2080
20. R.C. Nagarwal, D.N. Ridhurkar, and J.K. Pandit In vitro release kinetics and bioavailability of gastroretentive cinnarizine hydrochloride tablet AAPS PharmSciTech 11 2010 294 303
21. V.K. Pawar, S. Kansal, G. Garg, R. Awasthi, D. Singodia, and G.T. Kulkarni Gastroretentive dosage forms: a review with special emphasis on floating drug delivery systems Drug Delivery 18 2011 97 110
22. C. Sauzet, M. Claeys-Bruno, M. Nicolas, J. Kister, P. Piccerelle, and P. Prinderre An innovative floating gastro retentive dosage system: formulation and in vitro evaluation Int. J. Pharm. 378 2009 23 29
23. B.N. Singh, and K.H. Kim Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention J. Controlled Release 63 2000 235 259
24. L. Singh, A. Nanda, S. Sharma, and V. Sharma Design optimization and evaluation of gastric floating matrix tablet of glipizide Trop. J. Pharm. Res. 12 2014 869 876
25. H.H. Tønnesen, and J. Karlsen Alginate in drug delivery systems Drug Dev. Ind. Pharm. 28 2002 621 630
26. M.I. Tadros Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteers Eur. J. Pharm. Biopharm. 74 2010 332 339
27. R. Talukder, and R. Fassihi Gastroretentive delivery systems: a mini review Drug Dev. Ind. Pharm. 30 2004 1019 1028
28. S. Tiwari, and A. Rajabi-Siahboomi Extended-release oral drug delivery technologies: monolithic matrix systems K. Jain, Drug Delivery Systems 2008 Humana Press 217 243
29. A. Viridén, B. Wittgren, and A. Larsson Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets Eur. J. Pharm. Sci. 36 2009 297 309
30. C. Zhang, M. Xu, X. Tao, J. Tang, Z. Liu, Y. Zhang, X. Lin, H. He, and X. Tang A floating multiparticulate system for ofloxacin based on a multilayer structure: in vitro and in vivo evaluation Int. J. Pharm. 430 2012 141 150
31. X. Zhu, X. Qi, Z. Wu, Z. Zhang, J. Xing, and X. Li Preparation of multiple-unit floating-bioadhesive cooperative minitablets for improving the oral bioavailability of famotidine in rats Drug Delivery 21 2014 459 466
32. L. Zivanovic, G. Zigic, and M. Zecevic Investigation of chromatographic conditions for the separation of ofloxacin and its degradation products J. Chromatogr. A 1119 2006 224 230